376 related articles for article (PubMed ID: 28631555)
1. GRIK3: A novel oncogenic protein related to tumor TNM stage, lymph node metastasis, and poor prognosis of GC.
Gong B; Li Y; Cheng Z; Wang P; Luo L; Huang H; Duan S; Liu F
Tumour Biol; 2017 Jun; 39(6):1010428317704364. PubMed ID: 28631555
[TBL] [Abstract][Full Text] [Related]
2. Identification of differentially expressed signatures of long non-coding RNAs associated with different metastatic potentials in gastric cancer.
Song W; Liu YY; Peng JJ; Liang HH; Chen HY; Chen JH; He WL; Xu JB; Cai SR; He YL
J Gastroenterol; 2016 Feb; 51(2):119-29. PubMed ID: 26045391
[TBL] [Abstract][Full Text] [Related]
3. NOB1 Gene as a Potential Biomarker in Clinical Outcomes and Prognosis of Patients with Gastric Cancer.
Qi H; Wang Y
Clin Lab; 2018 Sep; 64(9):1469-1475. PubMed ID: 30274015
[TBL] [Abstract][Full Text] [Related]
4. FTO expression is associated with the occurrence of gastric cancer and prognosis.
Xu D; Shao W; Jiang Y; Wang X; Liu Y; Liu X
Oncol Rep; 2017 Oct; 38(4):2285-2292. PubMed ID: 28849183
[TBL] [Abstract][Full Text] [Related]
5. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
Zhang C; Zhang CD; Ma MH; Dai DQ
World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
[TBL] [Abstract][Full Text] [Related]
6. GPRC5A overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer.
Liu H; Zhang Y; Hao X; Kong F; Li X; Yu J; Jia Y
Tumour Biol; 2016 Jan; 37(1):503-10. PubMed ID: 26227221
[TBL] [Abstract][Full Text] [Related]
7. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
8. FLAD1 is up-regulated in Gastric Cancer and is a potential prediction of prognosis.
Hu P; Pan Y; Wang C; Zhang W; Huang H; Wang J; Zhang N
Int J Med Sci; 2020; 17(12):1763-1772. PubMed ID: 32714079
[No Abstract] [Full Text] [Related]
9. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of increased expression of RBM8A in gastric cancer.
Lv X; Cheng H
Braz J Med Biol Res; 2020; 53(4):e9290. PubMed ID: 32294703
[TBL] [Abstract][Full Text] [Related]
11. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.
Liu Y; Luo X; Deng J; Pan Y; Zhang L; Liang H
Tumour Biol; 2015 Apr; 36(4):2685-94. PubMed ID: 25472580
[TBL] [Abstract][Full Text] [Related]
12. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.
Cheng Y; Yang B; Xi Y; Chen X
Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer.
Liu Y; Liu H; Luo X; Deng J; Pan Y; Liang H
Tumour Biol; 2015 Jun; 36(6):4377-86. PubMed ID: 25627005
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer.
Peng XC; Zeng Z; Huang YN; Deng YC; Fu GH
Cancer Med; 2018 Jun; 7(6):2592-2600. PubMed ID: 29665316
[TBL] [Abstract][Full Text] [Related]
15. Activated Pak4 expression correlates with poor prognosis in human gastric cancer patients.
Li D; Zhang Y; Li Z; Wang X; Qu X; Liu Y
Tumour Biol; 2015 Dec; 36(12):9431-6. PubMed ID: 26124003
[TBL] [Abstract][Full Text] [Related]
16. LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients.
Cheng X; Zheng Z; Bu Z; Wu X; Zhang L; Xing X; Wang X; Hu Y; Du H; Li L; Li S; Zhou R; Wen XZ; Ji JF
PLoS One; 2015; 10(4):e0121559. PubMed ID: 25849595
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer.
Yang J
Med Oncol; 2020 Mar; 37(5):34. PubMed ID: 32219571
[TBL] [Abstract][Full Text] [Related]
18. High Expression of Retinoic Acid Induced 14 (RAI14) in Gastric Cancer and Its Prognostic Value.
He XY; Zhao J; Chen ZQ; Jin R; Liu CY
Med Sci Monit; 2018 Apr; 24():2244-2251. PubMed ID: 29654694
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and prognostic significance of miR-4317 expression in gastric cancer patients.
Zhang J; Tian ZL; Zhang WT; Cheng LM; Liu J; Cao YX; Zhang ZR
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2803-2808. PubMed ID: 31002131
[TBL] [Abstract][Full Text] [Related]
20. Increased chemokine receptor IL-17RA expression is associated with poor survival in gastric cancer patients.
Jiang YX; Li PA; Yang SW; Hao YX; Yu PW
Int J Clin Exp Pathol; 2015; 8(6):7002-8. PubMed ID: 26261590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]